WMSA
FRTX

Weiss Multi-Strategy Advisers’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-29
Closed -$106K – 1150
2013
Q4 		$106K Buy
+29
New +$110K ﹤0.01% 941

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Weiss Multi-Strategy Advisers's FRTX Position: Q1 2014 in Review

Weiss Multi-Strategy Advisers sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q1 2014, closing a stake of 29 shares — an estimated $106K sold.

Weiss Multi-Strategy Advisers first reported a position in FRTX in Q4 2013 and held it in 1 quarter. The position peaked at $106K in Q4 2013. 78 funds tracked by Wall St. Rank hold FRTX as of Q1 2014.

  • Weiss Multi-Strategy Advisers reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 29 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q1 2014, an estimated $106K.
  • Weiss Multi-Strategy Advisers first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Weiss Multi-Strategy Advisers's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $106K in Q4 2013.
  • 78 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q1 2014.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2014, filed 15 May 2014.